You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

PHENERGAN VC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Phenergan Vc patents expire, and when can generic versions of Phenergan Vc launch?

Phenergan Vc is a drug marketed by Ani Pharms and is included in two NDAs.

The generic ingredient in PHENERGAN VC is codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PHENERGAN VC?
  • What are the global sales for PHENERGAN VC?
  • What is Average Wholesale Price for PHENERGAN VC?
Summary for PHENERGAN VC
US Patents:0
Applicants:1
NDAs:2
Clinical Trials: 17
DailyMed Link:PHENERGAN VC at DailyMed
Drug patent expirations by year for PHENERGAN VC
Recent Clinical Trials for PHENERGAN VC

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Colorado, DenverPhase 4
University of FloridaPhase 4
South Valley UniversityPhase 1

See all PHENERGAN VC clinical trials

US Patents and Regulatory Information for PHENERGAN VC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms PHENERGAN VC phenylephrine hydrochloride; promethazine hydrochloride SYRUP;ORAL 008604-003 Apr 2, 1984 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Ani Pharms PHENERGAN VC W/ CODEINE codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride SYRUP;ORAL 008306-005 Apr 2, 1984 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

PHENERGAN VC Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Phenergan VC

Introduction

Phenergan VC, a combination of promethazine and phenylephrine, is a medication used to treat various symptoms such as allergy reactions, coughs, and colds. To understand its market dynamics and financial trajectory, we need to delve into several key areas, including market trends, competition, regulatory environment, and financial performance.

Market Trends

Pharmaceutical Market Overview

The pharmaceutical market is highly competitive and subject to various regulatory and economic factors. For medications like Phenergan VC, market trends are influenced by consumer demand, new drug developments, and changes in healthcare policies.

Generic vs. Brand Name

Phenergan, the brand name for promethazine, has been discontinued in the U.S., but generic versions are still available. This shift from brand to generic can significantly impact the financial trajectory of the drug, as generics typically have lower prices and higher market penetration[3].

Competitive Landscape

Antihistamines and Antiemetics Market

Phenergan VC competes in the antihistamines and antiemetics market, which includes a wide range of drugs. The competition is fierce, with many other antihistamines and combination products available. This competition can drive down prices and affect market share.

Combination Products

The combination of promethazine and phenylephrine in Phenergan VC offers a unique selling proposition, but it also faces competition from other combination products that may offer similar or better efficacy and safety profiles[3].

Regulatory Environment

FDA Approval and Monitoring

Phenergan VC, as a generic version of a previously approved drug, is subject to FDA regulations. Any changes in FDA policies or new safety data can impact the drug's market dynamics. For instance, if new side effects are reported, it could lead to increased scrutiny and potential market decline[3].

Labeling and Warnings

The drug label includes several warnings and potential side effects, such as respiratory depression, neuroleptic malignant syndrome, and cardiovascular issues. These warnings can influence prescribing habits and consumer confidence[2][3].

Financial Performance

Revenue Streams

The revenue for Phenergan VC is primarily generated through prescription sales. The financial performance can be affected by the number of prescriptions written, the price per unit, and the market share.

Impact of Generic Competition

The transition to generic status typically leads to a significant reduction in revenue due to lower pricing. However, generics often capture a larger market share due to their affordability, which can partially offset the revenue decline[3].

Consumer Demand and Prescribing Trends

Seasonal Demand

Demand for antihistamines and cough-cold medications like Phenergan VC can be seasonal, with higher demand during allergy seasons and cold and flu seasons.

Prescriber Preferences

Prescriber preferences play a crucial role in the financial trajectory of the drug. If prescribers prefer other antihistamines or combination products, it can negatively impact Phenergan VC's market share.

Side Effects and Safety Concerns

Serious Side Effects

Phenergan VC is associated with several serious side effects, including respiratory depression, seizures, and neuroleptic malignant syndrome. These safety concerns can lead to reduced prescriptions and lower revenue if not managed properly[2][3].

Patient Compliance

Patient compliance can also be affected by the side effect profile. Patients experiencing adverse effects may switch to alternative medications, impacting the drug's financial performance.

Pricing and Reimbursement

Pricing Strategies

The pricing of Phenergan VC is influenced by its generic status and competition. Lower prices can increase market share but may also reduce revenue per unit.

Reimbursement Policies

Reimbursement policies by insurance companies and government programs can significantly impact the financial trajectory. Changes in reimbursement rates or coverage can affect the drug's market dynamics[3].

Global Market Considerations

International Market Access

The availability and market performance of Phenergan VC can vary significantly across different countries due to local regulatory environments and market conditions.

Global Health Trends

Global health trends, such as the rise in allergy prevalence or changes in healthcare policies, can influence the demand for antihistamines and combination products like Phenergan VC.

Key Takeaways

  • Market Competition: Phenergan VC faces intense competition in the antihistamines and antiemetics market.
  • Generic Status: The transition to generic status affects pricing and market share.
  • Regulatory Environment: FDA regulations and safety warnings are critical factors.
  • Financial Performance: Revenue is influenced by prescription volume, pricing, and market share.
  • Consumer Demand: Seasonal demand and prescriber preferences are key drivers.
  • Safety Concerns: Serious side effects can impact market dynamics.

Frequently Asked Questions

1. What is Phenergan VC used for?

Phenergan VC is used to treat allergy symptoms such as itching, runny nose, sneezing, and itchy or watery eyes, as well as coughs and colds.

2. Why has the brand name Phenergan been discontinued?

The brand name Phenergan has been discontinued in the U.S., but generic versions of the drug are still available.

3. What are the serious side effects of Phenergan VC?

Serious side effects include respiratory depression, seizures, neuroleptic malignant syndrome, and cardiovascular issues.

4. How does the generic status of Phenergan VC affect its market dynamics?

The generic status typically leads to lower pricing and higher market penetration but can also result in reduced revenue per unit.

5. What factors influence the financial performance of Phenergan VC?

Factors include prescription volume, pricing, market share, seasonal demand, prescriber preferences, and reimbursement policies.

Cited Sources:

  1. Drugs.com - Phenergan Uses, Dosage & Side Effects
  2. DailyMed - Promethazine hydrochloride and phenylephrine hydrochloride solution
  3. California Prime Recovery - Promethazine Side Effects, Uses and Risks

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.